# Phase II Clinical Trial to Evaluate the Efficacy and Safety of LPM3480392 Injection for Moderate to Severe Pain After Orthopedic Surgery

> **NCT06467409** · PHASE2 · RECRUITING · sponsor: **Luye Pharma Group Ltd.** · enrollment: 150 (estimated)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Placebo
- **DRUG:** morphine hydrochloride injection
- **DRUG:** LPM3480392 Injection
- **DRUG:** LPM3480392 Injection
- **DRUG:** LPM3480392 Injection
- **DRUG:** LPM3480392 Injection

## Key facts

- **NCT ID:** NCT06467409
- **Lead sponsor:** Luye Pharma Group Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-26
- **Primary completion:** 2025-01
- **Final completion:** 2025-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06467409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06467409, "Phase II Clinical Trial to Evaluate the Efficacy and Safety of LPM3480392 Injection for Moderate to Severe Pain After Orthopedic Surgery". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06467409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*